Geneos Wealth Management’s IQVIA IQV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Sell
7,427
-424
-5% -$82.7K 0.03% 454
2025
Q4
$1.77M Sell
7,851
-1,250
-14% -$272K 0.04% 378
2025
Q3
$1.73M Sell
9,101
-510
-5% -$92.7K 0.04% 378
2025
Q2
$1.51M Sell
9,611
-8,784
-48% -$1.32M 0.04% 428
2025
Q1
$3.24M Buy
18,395
+10,171
+124% +$1.97M 0.05% 376
2024
Q4
$1.62M Buy
8,224
+13
+0.2% +$2.74K 0.06% 328
2024
Q3
$1.95M Sell
8,211
-3,967
-33% -$936K 0.07% 287
2024
Q2
$2.57M Buy
12,178
+40
+0.3% +$9.09K 0.11% 209
2024
Q1
$3.07M Buy
12,138
+649
+6% +$152K 0.14% 181
2023
Q4
$2.66M Buy
11,489
+157
+1% +$32.2K 0.13% 188
2023
Q3
$2.23M Buy
11,332
+1,616
+17% +$351K 0.11% 200
2023
Q2
$2.18M Buy
9,716
+4,590
+90% +$922K 0.11% 203
2023
Q1
$1.02M Sell
5,126
-956
-16% -$204K 0.06% 285
2022
Q4
$1.25M Sell
6,082
-812
-12% -$165K 0.08% 239
2022
Q3
$1.25M Sell
6,894
-974
-12% -$213K 0.09% 219
2022
Q2
$1.69M Sell
7,868
-1,021
-11% -$222K 0.08% 228
2022
Q1
$2.06M Buy
8,889
+253
+3% +$59.9K 0.09% 219
2021
Q4
$2.44M Buy
8,636
+657
+8% +$170K 0.09% 221
2021
Q3
$1.93M Buy
7,979
+275
+4% +$69.4K 0.07% 254
2021
Q2
$1.92M Sell
7,704
-943
-11% -$218K 0.07% 246
2021
Q1
$2.03M Sell
8,647
-864
-9% -$162K 0.06% 284
2020
Q4
$1.82M Buy
9,511
+882
+10% +$149K 0.07% 248
2020
Q3
$1.31M Sell
8,629
-260
-3% -$40.7K 0.07% 252
2020
Q2
$1.21M Buy
8,889
+1,182
+15% +$160K 0.07% 259
2020
Q1
$825K Buy
7,707
+4,279
+125% +$611K 0.06% 279
2019
Q4
$529K Buy
3,428
+204
+6% +$29.8K 0.03% 423
2019
Q3
$477K Buy
3,224
+76
+2% +$11.8K 0.03% 416
2019
Q2
$515K Buy
3,148
+280
+10% +$39.3K 0.03% 394
2019
Q1
$412K Buy
2,868
+124
+5% +$16.5K 0.03% 451
2018
Q4
$312K Buy
2,744
+1,072
+64% +$130K 0.02% 476
2018
Q3
$216K Buy
1,672
+365
+28% +$43.8K 0.01% 614
2018
Q2
$130K Buy
1,307
+124
+10% +$12.4K 0.01% 703
2018
Q1
$116K Buy
1,183
+162
+16% +$16.4K 0.01% 699
2017
Q4
$99K Buy
+1,021
New +$104K 0.01% 744

Other funds holding IQV

Geneos Wealth Management's IQV Position: Q1 2026 in Review

Geneos Wealth Management reduced its IQVIA (IQV) stake by 5.4% in Q1 2026, selling an estimated $82.7K and leaving 7,427 shares worth $1.27M. The position accounts for 0.03% of the portfolio, ranked #454.

Geneos Wealth Management first reported a position in IQV in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.24M in Q1 2025. 1,066 funds tracked by Wall St. Rank hold IQV as of Q1 2026.

  • Geneos Wealth Management held 7,427 shares of IQVIA worth $1.27M as of Q1 2026.
  • Geneos Wealth Management sold 424 IQVIA shares in Q1 2026, an estimated $82.7K.
  • IQVIA made up 0.03% of Geneos Wealth Management's portfolio in Q1 2026, its #454 holding.
  • Geneos Wealth Management first reported a position in IQVIA in Q4 2017 and has held it in 34 quarters since.
  • Geneos Wealth Management's IQVIA position peaked at $3.24M in Q1 2025.
  • 1,066 funds tracked by Wall St. Rank held IQVIA as of Q1 2026.

Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.